posteditor

posteditor

Insilico Medicine and Ribo Enter Strategic Collaboration Agreement: Leveraging AI Platform and Automated Lab for End-to-End Empowerment of RNA Interference and Oligonucleotide Therapeutics Development

B SHANGHAI, May 12, 2026 /PRNewswire/ — Insilico Medicine (“Insilico“, 03696.HK), a biotechnology company powered by generative artificial intelligence, today announced that the company has… Login to continue reading Login Sign up for complimentary access Sign Up Now Close